IL10 and inflammatory bowel disease: Another study utilizing modified mRNA LNPs investigated therapeutic delivery of interleukin 10 (IL-10) into Ly6C+ inflammatory leukocytes in a mouse model of inflammatory bowel disease (IBD) [91].